Hai cercato la traduzione di hospitalised da Inglese a Maltese

in serious cases, patients should be hospitalised.
f’każijiet gravi, il-pazjenti għandhom jiddaħħlu l- isptar.

a number of other persons are still hospitalised.
għadd ta' persuni oħra għadhom l-isptar.

the patient should be hospitalised and specific therapy for ohss started.
jekk l- ohss tkun qawwija ħafna, il- kura bil- gonadotrofina għandha titwaqqaf jekk tkun għadha għaddejja, u l- pazjenta tittieħed l- isptar biex tingħata terapija speċifika għall- ohss.

not relevant, as integrilin is intended for use only in hospitalised patients.
mhux rilevanti, peress li integrilin huwa maħsub biss għall-użu f’pazjenti li qegħdin l-isptar.

any other major disease for which you were hospitalised or received any medicine.
kwalunkwe marda serja oħra li minħabba fiha dħalt l-isptar jew irċevejt kwalunkwe mediċina.

integrilin is recommended for use only in adult, hospitalised patients in coronary care units.
integrilin huwa rrakkomandat biss g ħall-użu f’pazjenti adulti, li qeg ħdin -lisptar f’taqsimiet tal-kura koronarja.

both patients were hospitalised and received prophylactic oral probenecid and vigorous hydration for 3 to 7 days.
it- tnejn li huma kellhom jinżammu l-isptar fejn ingħataw trattament profilattiku b’probenecid mill-ħalq, filwaqt li ġew idratati b’mod vigoruż għal 3-7 t’ijiem.

in case of overdose, patients should be hospitalised for observation and appropriate supportive treatment should be given.
f’każ ta’ doża eċċessiva, il-pazjenti għandhom jittieħdu l-isptar għal osservazzjoni u l-kura meħtieġa għandha tingħata.

however, in case of overdose, patients should be hospitalised for observation and appropriate supportive treatment given.
l- ebda każ ta ’ doża eċċessiva ma ġie rrappurtat. f‘ każ ta 'doża eċċessiva, il- pazjent għandu jidħol l- isptar għall- osservazzjoni u jingħata kura ta ’ support xierqa.

in case of lactic acidosis, the patient should be hospitalised immediately (see section 4.9).
fil-każ ta' aċidożi lattika, il-pazjent għandu jiddaħħal l-isptar minnufih (ara sezzjoni 4.9).

if severe ohss occurs, it is recommended that gonadotropin treatment be stopped if still ongoing and that the patient be hospitalised and appropriate therapy be started.
f’każ ta’ ohss sever, huwa rakkomandat li l-kura b’gonadotropin titwaqqaf jekk tkun għadha għaddejja u li l-pazjenta tittieħed l-isptar u tinbeda terapija adattata.

to reduce risk of rehospitalisation, it is recommended that children receiving palivizumab who are hospitalised with rsv continue to receive monthly doses of palivizumab for the duration of the rsv season.
biex wieħed inaqqas ir-riskju li jkollhom jerġgħu jiddaħħlu l-isptar, huwa rakkomandat li tfal li jkun qed jingħataw palivizumab u li jinsabu fl-isptar bl-rsv, jibqgħu jirċievu dożi ta’ palivizumb kull xahar, tul l-istaġun ta’ rsv.

if you have to be hospitalised, you must first consult your health insurance fund, which will tell you what to do.this is not necessary for emergency hospitalisation.
għall-prodotti farmaċewtiċi miksuba permezz ta’ preskrizzjoni medika (riċetta), inti trid tħallas ammont għal kull preskrizzjoni li jvarja skond l-utilità soċjali u terapewtika tal-mediċina preskritta.

if metabolic acidosis is suspected, treatment with vipdomet should be discontinued and the patient hospitalised immediately (see section 4.9).
jekk l-aċidożi metabolika ikun issuspettat, il-trattament b’vipdomet għandu jitwaqqaf u l-pazjent jittieħed l-isptar immedjatament (ara sezzjoni 4.9).

if metabolic acidosis is suspected, treatment with the medicinal product should be discontinued and the patient hospitalised immediately (see section 4.9).
jekk ikun hemm suspett ta’ aċidożi metabolika, kura bil-prodott mediċinali għandha titwaqqaf u l-pazjent jiddaħħal l-isptar immedjatament (ara sezzjoni 4.9).

if metabolic acidosis is suspected, treatment with the medicinal product should be discontinued and the patient should be hospitalised immediately (see section 4.9).
jekk tkun issuspettata aċidożi metabolika, il-kura bil-prodott mediċinali għandha titwaqqaf u l-pazjent għandu jiddaħħal l-isptar immedjatament (ara sezzjoni 4.9).

the number reported as being hospitalised in direct consequence remains relatively low (which, in the absence of reliable data, may or may not be a true measure of actual harm).
l-għadd ta' persuni li ġew irrappurtati li ddaħħlu l-isptar b'konsegwenza diretta ta' dan għadu relattivament baxx (li, fin-nuqqas ta' data affidabbli, jista' jew jista' ma jkunx riflessjoni ġenwina tal-ħsara reali).

in a phase ii randomised placebo-controlled study of 48 hospitalised patients treated with enbrel or placebo for moderate to severe alcoholic hepatitis, enbrel was not efficacious, and the mortality rate in patients treated with enbrel was significantly higher after 6 months.
fi studju ta’ fażi ii, randomised, ikkontrollat bil-plaċebo, ta’ 48 pazjent li kienu l-isptar, ikkurati b’enbrel jew bil-plaċebo, għal epatite alkoħolika minn moderata sa severa, enbrel ma kienx effikaċi, u r-rata ta’ mortalità f’pazjenti kkurati b’enbrel kienet ogħla b’mod sinifikanti wara 6 xhur.

24.5% (793 out of 3,241) of patients treated with corlentor died or were hospitalised for the first time due to worsening heart failure, compared with 28.7% (937 out of 3,264) of patients treated with placebo.
24.5% (793 minn 3,241) tal-pazjenti li ngħataw kura b’corlentor mietu jew iddaħħlu l-isptar għall- ewwel darba minħabba insuffiċjenza kardijaka li marret għall-agħar, meta mqabbla ma’ 28.7% (937 minn 3,264) tal-pazjenti li ngħataw plaċebo.